65,437 trials
Psoriasis
Primary: Percentage of Participants Achieving 90% Improvement in Psoriasis Area and Severity Index (PASI) Score (PASI90) at Week 16 in Participants Who Received Risankizumab…
Bronchiectasis
Primary: Nontuberculous Mycobacterial (NTM) Disease — 188; 32 Events — p=0.19
Healthy Volunteers · Brain Lesion
Primary: Pharmacokinetic (PK) Parameter Cmax — 248.7; 524.5; 698.7; 992.0 µg/mL
Seasonal Allergic Rhinoconjunctivitis · Asthma
Primary: Change From Baseline With Montelukast+Bilastine Compared With Bilastine Monotherapy in SARC Symptoms — -3.2522; -3.4462 score on a scale — p=0.5721
Type 1 Diabetes
Primary: Percentage of Time Spent With Blood Glucose < 3.9 mmol/L (or 70 mg/dl) — 2; 6.7 percentage
Adenoma · Colonic Neoplasms
Primary: Adenoma Miss Rate — 52; 37 adenomas missed by first exam
Growth Hormone, Recombinant · Fatty Liver
Primary: Intrahepatocellular Lipid (IHCL) Content — -0.63; 0.11 % change from baseline — p=0.6
Healthy
Primary: Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Verapamil + R1 (T1) vs. R1)…
Head and Neck Cancer
Primary: Progression-free Survival — 54.2 months
Influenza and Acute Respiratory Viral Infections
Primary: Average Illness Duration — 4.6; 4.9 days — p=0.0242
Diabetes
Primary: Percent Glycosylated Hemoglobin — 8.38; 8.39 Percent glycosylated hemoglobin
Subarachnoid Hemorrhage
Primary: In-hospital Seizures — 3; 1 Participants
Healthcare Associated Infections · Methicillin Resistant Staphylococcus Aureus · Multi Drug Resistant Organisms
Primary: MRSA and VRE Clinical Cultures — 0.87; 0.79 Hazard Ratio (Intervention vs Baseline) — p=0.17
HIV Infections
Primary: Percentage of Participants With Plasma HIV-1 Ribonucleic Acid (RNA) <50 Copies Per Milliliter (c/mL) at Week 48 — 84; 70 Percentage of participants — p=<.001
Cancer-related Pain
Primary: Number of Participants With Reduction in Worst Pain Intensity or Reduction in 24hr Opioid Dose of at Least 30% Without Worsening of Pain Scores — 1; 2; 2; 1 Participants